Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Non Operating Income: 2021-2024

Historic Non Operating Income for Corcept Therapeutics (CORT) over the last 4 years, with Dec 2024 value amounting to $24.5 million.

  • Corcept Therapeutics' Non Operating Income fell 20.82% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year decrease of 0.18%. This contributed to the annual value of $24.5 million for FY2024, which is 42.07% up from last year.
  • Latest data reveals that Corcept Therapeutics reported Non Operating Income of $24.5 million as of FY2024, which was up 42.07% from $17.3 million recorded in FY2023.
  • Corcept Therapeutics' 5-year Non Operating Income high stood at $24.5 million for FY2024, and its period low was $529,000 during FY2021.
  • For the 3-year period, Corcept Therapeutics' Non Operating Income averaged around $15.1 million, with its median value being $17.3 million (2023).
  • Data for Corcept Therapeutics' Non Operating Income shows a peak YoY surged of 572.40% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Corcept Therapeutics' Non Operating Income stood at $529,000 in 2021, then skyrocketed by 572.40% to $3.6 million in 2022, then skyrocketed by 385.66% to $17.3 million in 2023, then skyrocketed by 42.07% to $24.5 million in 2024.